Guidance: Compounding Certain Ibuprofen Oral Suspension Products Under Section 503B of the Federal Food, Drug, and Cosmetic Act

TitleGuidance: Compounding Certain Ibuprofen Oral Suspension Products Under Section 503B of the Federal Food, Drug, and Cosmetic Act
ToC Doc Compounding Certain Ibuprofen Oral Suspension Products Under Section 503B of the Federal Food, Drug, and Cosmetic Act
Docket Number2023-01467
Type Notice
Subject Guidance:
Compounding Certain Ibuprofen Oral Suspension Products Under Section 503B of the Federal Food, Drug, and Cosmetic Act
Publication Date2023-01-25
Last Updated Date 2023-01-23 08:15:11 -0500
Last Public Inspection2023-01-23
Filed At2023-01-23T08:45:00.000-05:00
PDF 2023-01467_PI.pdf (78378 bytes)
Download TXT / HTML / JSON
Number of Pages 5
Filing Typespecial
AgenciesFood and Drug Administration

You can find the raw source document below...

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. OFR.report is not affiliated with the Office of the Federal Register or the US government in any way.

© OFR.report 2021